123 related articles for article (PubMed ID: 23905616)
41. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
42. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
[TBL] [Abstract][Full Text] [Related]
43. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
[TBL] [Abstract][Full Text] [Related]
44. Potential role of FDG PET/CT in evaluating patients with hepatic incidentalomas.
Grassetto G; Marzola MC; Chondrogiannis S; Maffione AM; Rampin L; Galeotti F; Colletti PM; Rubello D
Clin Nucl Med; 2014 Feb; 39(2):156-9. PubMed ID: 24321829
[TBL] [Abstract][Full Text] [Related]
45. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation.
Bettenworth D; Reuter S; Hermann S; Weckesser M; Kerstiens L; Stratis A; Nowacki TM; Ross M; Lenze F; Edemir B; Maaser C; Pap T; Koschmieder S; Heidemann J; Schäfers M; Lügering A
J Nucl Med; 2013 May; 54(5):748-55. PubMed ID: 23516311
[TBL] [Abstract][Full Text] [Related]
46. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.
Vos FJ; Bleeker-Rovers CP; Sturm PD; Krabbe PF; van Dijk AP; Cuijpers ML; Adang EM; Wanten GJ; Kullberg BJ; Oyen WJ
J Nucl Med; 2010 Aug; 51(8):1234-40. PubMed ID: 20660384
[TBL] [Abstract][Full Text] [Related]
47. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
[TBL] [Abstract][Full Text] [Related]
48. Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
Agarwal KK; Roy SG; Kumar R
PET Clin; 2016 Jan; 11(1):39-46. PubMed ID: 26590442
[TBL] [Abstract][Full Text] [Related]
49. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
[TBL] [Abstract][Full Text] [Related]
50. Low-dose computed tomography in assessment of pulmonary abnormalities in children with febrile neutropenia suffering from malignant diseases.
Zaleska-Dorobisz U; Olchowy C; Łasecki M; Sokołowska-Dąbek D; Pawluś A; Frączkiewicz J; Gorczyńska E
Adv Clin Exp Med; 2017 Jul; 26(4):695-701. PubMed ID: 28691431
[TBL] [Abstract][Full Text] [Related]
51. Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.
Wang XJ; Chan A
Curr Oncol Rep; 2017 Mar; 19(3):20. PubMed ID: 28271398
[TBL] [Abstract][Full Text] [Related]
52. Usefulness of
Gutiérrez-Villanueva A; Quintana-Reyes C; Martínez de Antonio E; Rodríguez-Alfonso B; Velásquez K; de la Iglesia A; Bautista G; Escudero-Gómez C; Duarte R; Fernández-Cruz A
Microorganisms; 2024 Jan; 12(2):. PubMed ID: 38399711
[TBL] [Abstract][Full Text] [Related]
53. [Septic shock following platelet transfusion contaminated with Citrobacter koseri in a child with postchemotherapy febrile neutropenia].
Tichit R; Saumet L; Marchandin H; Haouy S; Latry P; Sirvent N
Arch Pediatr; 2016 Jan; 23(1):86-9. PubMed ID: 26552624
[TBL] [Abstract][Full Text] [Related]
54. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy.
Zecha JAEM; Raber-Durlacher JE; Laheij AMGA; Westermann AM; Epstein JB; de Lange J; Smeele LE
Support Care Cancer; 2019 Oct; 27(10):3667-3679. PubMed ID: 31222393
[TBL] [Abstract][Full Text] [Related]
55. [Initial management of febrile neutropenia].
Badertscher L; Damak H; Mercier L; Décosterd D
Rev Med Suisse; 2016 Aug; 12(526):1321-1325. PubMed ID: 28671776
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.
Lee YM; Lockwood C
Int J Nurs Pract; 2013 Dec; 19(6):557-76. PubMed ID: 24330206
[TBL] [Abstract][Full Text] [Related]
57. Reducing radiation exposure in children with febrile neutropenia: can pulmonary MRI replace CT?
Zarnegar S; Giulino-Roth L
Leuk Lymphoma; 2016; 57(1):4-5. PubMed ID: 26062942
[No Abstract] [Full Text] [Related]
58. Chest CT Has Higher Yield for Infection than CT Sinus in Febrile Neutropenic Patients.
Choi WK; D'Sa A; Holman JN; Javed S; Thompson S; Nadgir RN
Curr Probl Diagn Radiol; 2022; 51(3):340-343. PubMed ID: 34334225
[TBL] [Abstract][Full Text] [Related]
59. Management of Infection and Febrile Neutropenia in Patients with Solid Cancer.
Aguado JM; Cruz JJ; Virizuela JA; Aguilar M; Carmona A; Cassinello J; Gudiol C; Jiménez Fonseca P; Lizasoain M; Marco F; Ruiz I; Ruiz M; Salavert M; Vicente D; Carratalà J
Enferm Infecc Microbiol Clin; 2017; 35(7):451-460. PubMed ID: 26279208
[TBL] [Abstract][Full Text] [Related]
60. Febrile Neutropenia.
Patel K; West HJ
JAMA Oncol; 2017 Dec; 3(12):1751. PubMed ID: 28750112
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
